Managers / Q1 2026
Tao Capital Management LP
CIK 0001802967 · 1 LETTERMAN DRIVE, SUITE C4-420, SAN FRANCISCO, CA, 94129 · 415-549-4970
Summary
Tao Capital Management LP reported $119M in U.S.-listed holdings across 8 positions for Q1 2026.
The portfolio is heavily concentrated: TWST alone accounts for 33.1% of reported value.
The book was largely unchanged from Q4 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $119M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TWSTTwist Bioscience Corporation | HELD | +0 | 828.8K | +$13M | $39M |
| TSLATesla, Inc. | HELD | +0 | 86.3K | −$7M | $32M |
| OUSTOuster, Inc. | HELD | +0 | 845.3K | −$3M | $16M |
| MDGLMadrigal Pharmaceuticals, Inc. | HELD | +0 | 21.0K | −$1M | $11M |
| HHyatt Hotels Corporation | HELD | +0 | 70.0K | −$1M | $10M |
| TXG10x Genomics, Inc. | HELD | +0 | 210.9K | +$1M | $4M |
| MASS908 Devices Inc. | HELD | +0 | 569.0K | +$495,014 | $3M |
| WRBYWarby Parker Inc. | HELD | +0 | 134.5K | −$96,821 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TWSTTwist Bioscience Corporationhistory → | Common Stock | 33.14% | $39M | 828.8K |
| 2 | TSLATesla, Inc.history → | Common Stock | 26.98% | $32M | 86.3K |
| 3 | OUSTOuster, Inc.history → | Common Stock | 13.07% | $16M | 845.3K |
| 4 | MDGLMadrigal Pharmaceuticals, Inc.history → | Common Stock | 9.25% | $11M | 21.0K |
| 5 | HHyatt Hotels Corporationhistory → | Class B Common Stock | 8.47% | $10M | 70.0K |
| 6 | TXG10x Genomics, Inc.history → | Class A Common Stock | 3.77% | $4M | 210.9K |
| 7 | MASS908 Devices Inc.history → | Common Stock | 2.93% | $3M | 569.0K |
| 8 | WRBYWarby Parker Inc.history → | Class A Common Stock | 2.38% | $3M | 134.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $119M | 8 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $116M | 8 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $132M | 10 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $136M | 9 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $116M | 9 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $143M | 10 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $110M | 10 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $122M | 10 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | Under review | 10 | May 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $109,313 | 12 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $129,125 | 11 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $136,566 | 14 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $125,698 | 15 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 16 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $153M | 17 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $144M | 17 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $274M | 17 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $327M | 15 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $375M | 14 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $436M | 9 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $346M | 8 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $407M | 6 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $310M | 7 | Nov 25, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $253M | 4 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $213M | 4 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $203M | 4 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.